Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinduoduo, CV Sciences, and Ampio and Encourages Investors to Contact the Firm
21 oct. 2018 18h00 HE
|
Bragar Eagel & Squire
NEW YORK, Oct. 21, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pinduoduo Inc., CV Sciences,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LogMeIn, Pinduoduo, Nevro, and CV Sciences and Encourages Investors to Contact the Firm
16 oct. 2018 19h52 HE
|
Bragar Eagel & Squire
NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of LogMeIn, Inc., Pinduoduo...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CV Sciences, Lannett, and Ampio and Encourages Investors to Contact the Firm
10 oct. 2018 19h19 HE
|
Bragar Eagel & Squire
NEW YORK, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CV Sciences, Inc., Lannett...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nevro, CV Sciences, and Lannett and Encourages Investors to Contact the Firm
03 oct. 2018 18h56 HE
|
Bragar Eagel & Squire
NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Nevro Corp., CV Sciences,...
Streetwise Reports Examines a Cannabis Company that Has Better Numbers than Tilray at 1/25th the Price
25 sept. 2018 13h17 HE
|
Streetwise Reports Llc
SAN FRANCISCO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Tilray's wild fluctuations have grabbed the headlines the past few days, but Fincom Investment Partners profiles a rapidly emerging player in the...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CV Sciences, Papa John’s, and Qurate and Encourages Investors to Contact the Firm
18 sept. 2018 20h07 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CV Sciences, Inc., Papa...
CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation
10 sept. 2018 19h33 HE
|
CV Sciences, Inc.
First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
CV Sciences, Inc. provides corporate update to shareholders
30 août 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like to assure our shareholders that we are keenly aware of recent...
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CV Sciences, Inc. (CVSI) and Encourages Investors to Contact the Firm
29 août 2018 19h10 HE
|
Bragar Eagel & Squire
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the District of Nevada on behalf of...
CV Sciences, Inc. Responds to Class Action Lawsuit
28 août 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) has been informed of a class action lawsuit filed against the Company...